•  
  •  
  •  
  •  

2025-10-25 01:52:27

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Vikran Engineering Ltd receives order worth Rs. 354.21 crores
  • NRB Bearings Ltd declares interim dividend of Rs. 2.50
  • Latent View Analytics Ltd reports Rs. 44.39 crores consolidated net profit in Q2 FY2026
  • MosChip Technologies Ltd posts consolidated PAT of Rs. 12.15 crores in Q2FY26
  • eClerx Services Ltd consolidated Q2FY26 PAT climbs to Rs. 183.19 crores

Keywords Selected:  PI

Research

  • Health segment drives robust growth for insurance sector in FY2024; financial performance strong despite impact of natural catastrophic events - ICRA
  • Acuité Ratings & Research comments on WPI Inflation - Dec'22
  • Acuité Ratings & Research comments on CPI Inflation - Nov'22
  • UPI transactions witnesses 650% rise at rural and semi-urban stores: PayNearby
  • Acuité Ratings & Research comments on WPI - Aug'22
  • WPI inflation further eases to an 11-month low - WPI Aug-22 - Acuité Ratings
  • WPI inflation eases to a five month low - Acuité Ratings
  • June CPI Offers some comfort, but risks persist - CPI - June'22 - Acuité Ratings
  • CPI Inflation - June 2022 - Comments from Industry Experts
  • Banks - Modifications to PPI and its impact on cards - Negligible impact, if any, for stocks under coverage
  • WPI inflation print moved up sharply to 14.55% in Mar-22 from 13.11% in Feb-22 - Acuité Ratings
  • India's CPI inflation print rose sharply to 6.95% YoY in Mar-22 from 6.07% in Feb-22 - Acuité Ratings
  • Acuité's CPI inflation forecast currently stands at 5.9% for FY23 - Acuité Ratings
  • BFSI Sector Update - Connecting The Dots - UPI drags payments fee yields; BNPL endgame ahead
  • The WPI print for Feb-22 inched up to 13.11% YoY from 12.96% in Jan-22 - Acuité Ratings
  • Economy: Higher oil prices in H1CY22 (and lower in H2) to bring forward India's rate hikes
  • Acuité's CPI inflation forecast currently stands at 5.0% for FY23
  • CPI inflation forecast of 5.5% for FY22 - Acuité Ratings & Research
  • WPI - 21 Dec'21 - Acuite Ratings & Research
  • Acuite expects a further pass through of input costs in manufactured goods - WPI Nov'21
  • Peak in the headline wholesale inflation is behind us - WPI Sep'21 - Acuité Insights
  • Expect CPI to be 5.5% for FY22 - Acuite Ratings

Market Commentary

  • Daily Market Commentary - June 8, 2022 - Bonanza Portfolio
  • Indian rupee to depreciate to 76 per US$ during December 2021 - Economy Observer - Dun & Bradstreet

Stock Report

  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Nestlé India signs MOU with Ministry of Food Processing Industries at World Food India Summit
  • Godrej Agrovet signs MoU with MoFPI to strengthen food processing & innovation
  • USFDA successfully completes inspection at Indoco's API manufacturing facility at Patalganga with zero observations
  • Parsvnath Palacia, Sector Pi, Greater Noida
  • Paytm Launches Postpaid, a Credit Line on UPI, in Partnership with Suryoday Small Finance Bank
  • Koanna International FZ LLC and PPI Launch Joint Venture to Build New Pharma Manufacturing Facility in Saudi Arabia
  • Sigachi Industries Secures ToR approval for its Upcoming API and Specialty Chemicals Manufacturing Facility in Orvakal, Andhra Pradesh State
  • IndusInd Bank signs MoU with AIC STPINEXT to Empower India's Startup Ecosystem
  • Lasa Supergenerics Ltd expands Manufacturing Capacity of API Albendazole to meet Global Demand
  • Wanbury Limited launching two new products, Formulation - Branded Hematinic Iron tablets, WANBURY C-RED and API- KETAMINE HYDROCHLORIDE
  • Closure of USFDA inspection at Zydus' API Unit 1 at Ankleshwar, Gujarat
  • J B Chemicals & Pharmaceuticals Ltd successfully completes USFDA inspection at API facility
  • EDQM issues CEP Certificate for IOL Chemicals and Pharmaceuticals Ltd's API Quetiapine Fumarate
  • Paytm UPI enables Seamless Trading on Equity Broking Apps with Automatic Payment Deduction Directly from Bank Accounts
  • Orchid Pharma's Alathur API facility successfully completes USFDA inspection
  • Shilpa Pharma Lifesciences Limited, Received CEP from EDQM for API, Teriflunomide
  • Selan Exploration Technology Ltd - Cambay Field update
  • Shilpa Pharma Lifesciences Limited, received CEP from EDQM for API, Nifedipine
  • Shilpa Pharma Lifesciences Limited, Received CEP from EDQM for API, Octreotide
  • NIIT Learning Systems Limited Accredited Gold Standard by the Learning and Performance Institute for the 9th Consecutive Year
  • Shilpa Pharma Lifesciences Limited, received CEP from EDQM for API, Desmopressin
  • Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
  • Anuh Pharma Ltd received EDQM approval for CEP of Allopurinol API

Industry News

  • UPI for Secondary Market

Latest Post

  • Vikran Engineering Ltd receives order worth Rs. 354.21 crores
  • NRB Bearings Ltd declares interim dividend of Rs. 2.50
  • Latent View Analytics Ltd reports Rs. 44.39 crores consolidated net profit in Q2 FY2026
  • MosChip Technologies Ltd posts consolidated PAT of Rs. 12.15 crores in Q2FY26
  • eClerx Services Ltd consolidated Q2FY26 PAT climbs to Rs. 183.19 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024